Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We used non-direct immunofluorescence microscopy, immunoblotting and affinity chromatography on A-protein Superose to study antibodies to neural tissue antigens in sera from 11 patients with
ALS
and from 10 healthy donors. In all sera the majoric antigens had molecular masses of 150-200kD,
70kD
and 50kD. No consistent differences were found between
ALS
patients and controls. Antibodies to 50kD and
70kD
proteins from patients with
ALS
were found to be mostly IgM, whereas antibodies from control sera were mostly IgG. Antibodies to high molecular weight proteins (150-200kD) in
ALS
and controls belonged to both classes of immunoglobulins. Immunoblotting studies of neural tissue proteins after treatment blots with alkaline phosphatase showed considerable decrease of antibodies binding to neural tissue antigens in sera of
ALS
patients. The same results were obtained by immunofluorescence assay. The alkaline phosphatase experiments suggest that in
ALS
patients the sera antibodies are directed mainly against phosphoepitopes in protein antigenic determinants of the neural tissue. This results can lead to conclusion of a role for the altered phosphorylation of the neural proteins in the
ALS
pathogenesis.
...
PMID:[Analysis of serum antibodies to nerve tissue antigens in patients with lateral amyotrophic sclerosis]. 751 64